scholarly article | Q13442814 |
P356 | DOI | 10.1002/JPS.2600680515 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0022354915426280?httpAccept=text/xml |
https://api.elsevier.com/content/article/PII:S0022354915426280?httpAccept=text/plain | ||
P698 | PubMed publication ID | 430493 |
P2093 | author name string | D. W. Bourne | |
McAllister RG Jr | |||
R. G. McAllister | |||
T. G. Tan | |||
P2860 | cites work | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction | Q44602686 | ||
Fluorometric Assay of Verapamil in Biological Fluids and Tissues | Q44892136 | ||
Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations | Q45274238 | ||
A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function | Q46536654 | ||
Editorial: Calcium responses ("calcium spikes"). | Q52723771 | ||
Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias | Q55359543 | ||
Physiological disposition of verapamil in man | Q57072038 | ||
A protective effect of verapamil on hypoxic heart muscle | Q67863453 | ||
Metabolism of [14C]-verapamil | Q70591457 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmaceutical science | Q7180763 |
verapamil | Q410291 | ||
P304 | page(s) | 574-577 | |
P577 | publication date | 1979-05-01 | |
P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
P1476 | title | GLC Assay of Verapamil in Plasma: Identification of Fluorescent Metabolites after Oral Drug Administration | |
P478 | volume | 68 |